The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Curtis, G. C.
* Articles by Nesse, R. M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Curtis, G. C.
* Articles by Nesse, R. M.

Am J Psychiatry 1982; 139:1043-1046
Copyright © 1982 by American Psychiatric Association


REGULAR ARTICLES

The dexamethasone suppression test in panic disorder and agoraphobia

GC Curtis, OG Cameron and RM Nesse

Reports that imipramine and phenelzine prevent panic attacks in agoraphobia suggest the possibility that agoraphobia and/or panic disorder might be a clinical manifestation of underlying depression. To test this hypothesis, dexamethasone suppression tests (DSTs) were performed in 10 patients meeting DSM-III criteria for agoraphobia with panic attacks, 6 for panic disorder, and 4 whose diagnosis could have been either panic disorder or agoraphobia except that another axis I disorder precluded such a diagnosis. Abnormal DSTs were observed in only 3 patients and appeared to be attributable to causes other than panic attacks or agoraphobia. The results suggest that panic attacks and endogenous depression are separate disorders and that the antipanic properties of imipramine and phenelzine are separate from their antidepressant actions.


This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
J. L. Abelson and G. C. Curtis
Hypothalamic-Pituitary-Adrenal Axis Activity in Panic Disorder: 24-Hour Secretion of Corticotropin and Cortisol
Arch Gen Psychiatry, April 1, 1996; 53(4): 323 - 331.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
G. W. Arana, R. J. Baldessarini, and M. Ornsteen
The Dexamethasone Suppression Test for Diagnosis and Prognosis in Psychiatry: Commentary and Review
Arch Gen Psychiatry, December 1, 1985; 42(12): 1193 - 1204.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
T. W. Uhde, L. M. Bierer, and R. M. Post
Caffeine-Induced Escape From Dexamethasone Suppression
Arch Gen Psychiatry, July 1, 1985; 42(7): 737 - 738.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
O. G. Cameron, C. B. Smith, P. J. Hollingsworth, R. M. Nesse, and G. C. Curtis
Platelet {alpha}2-Adrenergic Receptor Binding and Plasma Catecholamines: Before and During Imipramine Treatment in Patients With Panic Anxiety
Arch Gen Psychiatry, December 1, 1984; 41(12): 1144 - 1148.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
M. F. Shapiro, A. F. Lehman, and S. Greenfield
Biases in the Laboratory Diagnosis of Depression in Medical Practice
Arch Intern Med, November 1, 1983; 143(11): 2085 - 2088.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
W. Matuzas and R. M. Glass
Treatment of Agoraphobia and Panic Attacks
Arch Gen Psychiatry, February 1, 1983; 40(2): 220 - 222.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1982 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org